Recon: China Pushes for Lower Cancer Drug Prices

• Trump Fails at Lowering Drug Prices as Costs Keep Going Up (Bloomberg)
• This Form of Ambien Now Costs Over 800% More (WSJ-$)
• Lawmaker asks Pfizer to make recent rollback on drug prices permanent (Stat-$)
• Drug to Treat Smallpox Approved by FDA, a Move Against Bioterrorism (NYT-$) (Endpoints) (FDA)
• Drug industry takes center stage in Senate race, as Hugin punches back against Menendez (Stat-$) (Endpoints)
• Following EU Recalls, FDA Announces Voluntary Recall of Drugs Containing Valsartan (Focus)

• China vaccine producer under investigation (ECNS)
• China pushes for lower cancer drug prices: Xinhua (Reuters) (Pharmaphorum) (ECNS)
• Novartis is the implied villain of the most popular film in China right now (Stat-$)
• Interview – Why Immatics could soon become the next listed cell therapy player (EP Vantage)
• Investment in digital health and access to drugs at the core of Austrian Presidency (Euractiv)
• Access to medical devices for Universal Health Coverage and achievement of SDGs (WHO)
• Otsuka has high hopes for its ‘drug creation engine’ acquisition (Pharmaphorum)
• Polio: The Odyssey of Eradication, by Thomas Abraham (FT-$)
• NICE guideline set to address variation in provision of services for adults with cerebral palsy (NICE)

• Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic (Reuters) (Law360-$)
• Why Aren't Prison Inmates With Hepatitis C Being Treated? (Forbes)
• Event – Sink or swim for fish oils, and Amarin (EP Vantage)
• Richard Lehman’s journal review—16 July 2018 (BMJ)
• Life Sciences Court Report (Patent Docs)
• ICER Weekly View 07-13-18 (ICER)
• Big Pharma & The Rise Of Gangster Capitalism (Zero Hedge)
• PhRMA Statement on Efforts to Support Real-World Evidence (PhRMA)
• Preserving Stewardship Of The Patient’s Story (Health Affairs)
• Beating the Next Superbug Needs a Big Pharma Payoff (Bloomberg)
• Could Brain Stimulation Slow Cancer? (Scientific American)
• Job Cuts Seen At Dr Reddy’s Amid Cost Recalibration (Scrip-$)
• Scientist searching to cure her own prion disease reveals an industry alliance (Stat-$)
• Midyear analysis: Partnering transactions show no signs of slowing down in 2018 (BioWorld-$)
• Irregular flow improves bioreactor platelet production (BioWorld)
• Petition to Request an Exemption from 100‑Percent Identity Testing of Dietary Ingredients (Lachman Consultants)
• Biotech Movers and Shakers for July 16 (BioSpace)
• FDA AdComm backs GlaxoSmithKline’s one-shot P. vivax malaria therapy (Fierce)
• Hemophilia, the musical: BioMarin sponsors one-of-a-kind performance created by teens (Fierce)
• McCann Health fires chief creative officer over conduct code violation (Fierce)  

• FDA approves enzalutamide for castration-resistant prostate cancer (FDA)
• FDA grants accelerated approval to Yervoy for MSI-H or dMMR metastatic colorectal cancer (Cancer Letter)
• Vant commander Ramaswamy heads back to Nasdaq with a $150M pitch — are investors ready to forgive Axovant? (Endpoints)
• Chasing Biogen, the Pliant crew banks a $62M round to fuel their shot at fibrosis targets (Endpoints)
• Pharma Q2 Results Preview: Johnson & Johnson And Novartis (Scrip-$)
• Spero Awarded up to $54 Million by BARDA and DTRA to Support SPR994 Development (Press)
• Tonix Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for TNX-102 SL for Treatment of Agitation in Alzheimer’s Disease (Press)
• Idera Pharmaceuticals provides update (Press)
• Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (Press)
• Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering Ravicti (glycerol phenylbutyrate) Oral Liquid (Press)
• Guardian Pharmacy Services Secures $60 Million to Fuel Expansion (Press)

• Stryker wins FDA approval for Surpass Streamline brain aneurysm device (MassDevice)
• Insulet settles shareholder suit over Omnipod Eros device (MassDevice)
• Nevro Q2 prelims top expectations on The Street (MassDevice)
• Kypha acquires Dublin, Ireland-based diagnostics company, Biosensia (PharmaBiz)
• AdvaMed Statement on FDA Medical Device Communications Guidance (Press)
• Reducing the risks of information security breaches with ISO/IEC 27005 (ISO)

• AmerisourceBergen response to Sen. McCaskill (Letter)
• Wyden Statement on Tom Price HHS Inspector General Report (Press)
• Former HHS secretary Tom Price’s air travel wasted $341,000 in government funds, watchdog says (Washington Post-$)
• Tepid Reactions to Medicare Fee Schedule Proposal (MedPage Today)
• Reducing Health Care Costs: Eliminating Excess Health Care Spending and Improving Quality and Value for Patients (Senate HELP Committee)
• Patients, Advocates To FDA: Repurpose Drugs, Waive Prescribing Restrictions (InsideHealthPolicy-$)

• FDA Advisory Committee Calendar

• Criminal involvement in falsification of medicines: maximum prison sentence ranges from one to 15 years across EU, says report (European Commission)
• Annual review of good clinical practice referrals (MHRA)
• Substances that may require child-resistent packages (Swedish Medical Products Agency)

• China expands surveillance of sewage to police illegal drug use (Nature News)
• Lupin down despite Goa plant approval from UK regulator (PharmaLetter-$)

• Wockhardt sets up 13-bed dialysis unit in South Mumbai with 3 extra beds for hepatitis B/C, HIV positive patients (PharmaBiz)

• Australian Public Assessment Reports for prescription medicines (AusPARs) (TGA)

• Australia Canada Singapore Switzerland (ACSS) Consortium – Erleada approval (Health Canada)
• Product Monograph Brand Safety Updates (Health Canada)

• William McBride, Who Warned About Thalidomide, Dies at 91 (NY Times-$)
• Breast-Feeding or Formula? For Americans, It’s Complicated (NYT) (NPR)
• Backers of Tesla and SpaceX fund 29-year-old Alice Zhang’s AI-powered neuroscience startup (Endpoints)
• New Weapons Against Antibiotic-Resistant Bacteria (Bloomberg)
• Biomarker’s Potential for Diagnosing Traumatic Brain Injury Solidified (GEN)